Mangalam Drugs and Organics Share Price
14 Aug, 2026 3:54 PM (IST)
Mangalam Drugs and Organics Performance
- Today's Low
- ₹28
- Today's High
- ₹30
- 52 Week Low
- ₹23
- 52 Week High
- ₹84
- Open Price₹29
- Previous Close₹28
- Volume48,956
- 50 DMA₹28.00
- 100 DMA₹30.00
- 200 DMA₹38.00
Mangalam Drugs and Organics Chart
Investment Returns
- Over 1 Month + 0.5%
- Over 3 Month -6.28%
- Over 6 Month -14.13%
- Over 1 Year -66.08%
Smart Investing Starts Here Start SIP with Mangalam Drugs and Organics for Steady Growth!
Mangalam Drugs and Organics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -1.2
- PEG Ratio
- 0
- Market Cap Cr
- 44
- P/B Ratio
- 0.4
- Average True Range
- 1.4
- EPS
- -24.2
- Dividend Yield
- 0
- MACD Signal
- -0.1
- RSI
- 59.37
- MFI
- 65.87
Latest Stock News Updates
Newspaper publication for declaration of Un-audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2026
- BSE India
- 3 days 1 hour ago
Appointment of Secretarial Auditor of the Company for term of 5 years from F.Y. 2026-27 to 2030-31 subject to approval of shareholders in ensuing 53rd AGM of the Company
- BSE India
- 3 days 23 hours ago
Appointment of Statutory Auditor for the period of 5 years subject to approval of sharehoders at ensuing 53rd Annual General meeting.
- BSE India
- 4 days ago
Mangalam Drugs and Organics Financials
Mangalam Drugs and Organics Technicals
EMA & SMA
- Bearish Moving Average 5
- Bullish Moving Average 11
- 20 Day
- ₹27.40
- 50 Day
- ₹28.00
- 100 Day
- ₹30.00
- 200 Day
- ₹38.00
Resistance and Support
- R3 31.70
- R2 30.80
- R1 29.40
- S1 27.10
- S2 26.20
- S3 24.80
Mangalam Drugs and Organics Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-12 | Quarterly Results | |
| 2026-05-14 | Audited Results | |
| 2026-03-26 | Others | Inter-alia, to consider 1. Taking note of Resignation of Ms. Anuradha Pandey as Company Secretary & Compliance Officer. 2. Appointment of Ms. Shweta Patel as Company Secretary & Compliance Officer. |
| 2026-02-06 | Others | |
| 2026-01-15 | Quarterly Results |
About Mangalam Drugs and Organics
Mangalam Drugs and Organics engaged in the manufacture and sale of Active Pharmaceutical Ingredients (API) for various therapeutic segments viz. Anti Malaria, Anti-Retrovirat, Anti-Hypertensive etc. View More- NSE Symbol
- MANGALAM
- BSE Symbol
- 532637
- ISIN
- INE584F01014
Similar Stocks to Mangalam Drugs and Organics
Popular Stocks
Mangalam Drugs and Organics FAQs
Mangalam Drugs and Organics share price is ₹28 As on 16 August, 2026 | 17:31
The Market Cap of Mangalam Drugs and Organics is ₹44.4 Cr As on 16 August, 2026 | 17:31
The P/E ratio of Mangalam Drugs and Organics is -1.2 As on 16 August, 2026 | 17:31
The PB ratio of Mangalam Drugs and Organics is 0.4 As on 16 August, 2026 | 17:31
The 52 week High & Low of Mangalam Drugs and Organics is ₹84.2/₹22.8 respectively As on 16 August, 2026 | 17:31
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.